VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Molecular targeted therapies in endometrial cancer
Molecular targeted therapies in endometrial cancer
Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review.
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies. Oncogene. 2016 09 01; 35(35):4663-74.
View in:
PubMed
subject areas
Adult
Aged
Animals
Carcinoma, Renal Cell
Cell Line, Tumor
Cell Proliferation
Drug Resistance, Neoplasm
Female
Gene Expression Regulation, Neoplastic
Humans
Male
Middle Aged
Molecular Targeted Therapy
Protein Kinase Inhibitors
ras GTPase-Activating Proteins
Signal Transduction
Sirolimus
TOR Serine-Threonine Kinases
authors with profiles
CRAIG AUTHEMENT